About Steroid hormone receptor ERR1
Steroid hormone receptor ERR1 (ESRRA) is a protein
from Homo sapiens identified by UniProt accession
P11474, 423 residues long.
MolForge cross-references it against 0 known binders and
243 disease associations.
Target properties
| Protein name | Steroid hormone receptor ERR1 |
| UniProt accession | P11474 |
| Gene | ESRRA |
| Organism | Homo sapiens |
| Length | 423 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (4)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (243)
Diseases linked to this target (Open Targets).
- adenoid cystic carcinoma · score 0.18
- breast cancer · score 0.11
- triple-negative breast cancer · score 0.11
- neoplasm · score 0.11
- osteosarcoma · score 0.10
- cancer · score 0.08
- non-alcoholic fatty liver disease · score 0.08
- oral squamous cell carcinoma · score 0.08
- non-small cell lung carcinoma · score 0.08
- lung adenocarcinoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P11474-F1 | alphafold | PREDICTED | 77.01 | — |
Amino-acid sequence (423 residues)
MSSQVVGIEP LYIKAEPASP DSPKGSSETE TEPPVALAPG PAPTRCLPGH KEEEDGEGAG PGEQGGGKLV LSSLPKRLCL VCGDVASGYH YGVASCEACK AFFKRTIQGS IEYSCPASNE CEITKRRRKA CQACRFTKCL RVGMLKEGVR LDRVRGGRQK YKRRPEVDPL PFPGPFPAGP LAVAGGPRKT AAPVNALVSH LLVVEPEKLY AMPDPAGPDG HLPAVATLCD LFDREIVVTI SWAKSIPGFS SLSLSDQMSV LQSVWMEVLV LGVAQRSLPL QDELAFAEDL VLDEEGARAA GLGELGAALL QLVRRLQALR LEREEYVLLK ALALANSDSV HIEDAEAVEQ LREALHEALL EYEAGRAGPG GGAERRRAGR LLLTLPLLRQ TAGKVLAHFY GVKLEGKVPM HKLFLEMLEA MMD
Explore Steroid hormone receptor ERR1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets